Can neurodegeneration and neuroinflammation reinforce each other?

Neurodegenerative disorders, particularly Alzheimer-related disease, commonly show neuronal injury alongside glial and complement activation. The evidence supports a biologically plausible, potentially self-amplifying relationship, although much human evidence remains observational.

Injury-triggered immune activation

• Injured neurons release damage-associated molecular patterns—extracellular ATP, mitochondrial DNA, HMGB1, reactive oxygen species, and cellular debris—that engage microglial and astrocytic TLRs, RAGE, NLRP3, cGAS, TREM2, and purinergic receptors.
• Human Alzheimer pathology identifies reactive glia and complement products (C1q, C3 fragments, terminal-pathway products) near dystrophic neurites, vulnerable synapses, plaques, and tau pathology. TSPO-PET signal is associated with amyloid/tau burden and poorer cognition, although TSPO is not microglia-specific.
• Rising plasma neurofilament light tracks atrophy, hypometabolism, cognitive impairment, and faster deterioration, supporting its use as a noninvasive neuronal-injury marker rather than an Alzheimer-specific marker.

Inflammatory amplification of dysfunction

• Activated microglia release TNF-α, IL-1α, IL-6, nitric oxide, and complement/inflammasome-related signals. These mediators can impair synaptic function and promote neurotoxic astrocyte signaling.
• A defined feed-forward route involves injury-induced glial C1q/C3 expression: C1q initiates classical complement activation, C3b/iC3b tags synapses, and microglial CR3 mediates engulfment. Excessive pruning of potentially functional synapses can contribute to early synaptic dysfunction and cognitive decline.
• Prospective human data most consistently link higher IL-6 with later cognitive decline; CSF YKL-40, ICAM-1, VCAM-1, IL-15, Flt-1, and sTREM2 also associate with tau, decline, Alzheimer risk, or neurofilament light.

Bottom line

• The proposed cycle is supported by convergent mechanistic, pathological, biomarker, and longitudinal evidence: neuronal injury can activate glial/complement immune pathways, and persistent inflammatory signaling can further disrupt synapses and neuronal function. Its exact magnitude and causal importance in individual patients remain uncertain because definitive target-specific human intervention evidence is limited.